vidarabine has been researched along with pentostatin in 113 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 32 (28.32) | 18.7374 |
| 1990's | 42 (37.17) | 18.2507 |
| 2000's | 33 (29.20) | 29.6817 |
| 2010's | 5 (4.42) | 24.3611 |
| 2020's | 1 (0.88) | 2.80 |
| Authors | Studies |
|---|---|
| Inoue, T; Kato, T; Kato, Y; Kinoshita, T; Kuno, M; Nakamura, K; Nakanishi, I; Naoe, Y; Okumura, H; Seki, N; Tanaka, K; Terasaka, T; Tsuji, K | 1 |
| Inoue, T; Kato, T; Kato, Y; Kinoshita, T; Kuno, M; Nakamura, K; Nakanishi, I; Tanaka, K; Terasaka, T; Tsuji, K | 1 |
| Cheson, BD | 8 |
| Kantarjian, H; Keating, MJ; Koller, C; O'Brien, S; Plunkett, W; Robertson, L | 1 |
| Phyliky, RL; Tefferi, A | 1 |
| Blatt, J; Hammond, GD; Krailo, MD; Miser, JS; Reaman, GH; Roloff, J | 1 |
| Gribbin, TE | 1 |
| Hirose, M; Inaba, S; Kuroki, Y; Shimoyama, M | 1 |
| Butkiewicz, NJ; Lieberman, M; Lim, J; Lin, C; Miller, GH; Ostrander, M; Schwartz, J | 1 |
| Matsumoto, SS; Mendelsohn, J; Yu, AL | 1 |
| O'Brien, WJ | 1 |
| Helland, S; Ueland, PM | 2 |
| Heike, T; Katamura, K; Kubota, M; Mikawa, H; Shinomiya, K | 1 |
| Kontinen, VP; Pispa, JP | 1 |
| Imamura, N; Ishikawa, H; Kimura, K; Kuga, H; Okano, K; Omura, S; Takahashi, Y; Tanaka, H; Yamazaki, Y | 1 |
| Iliakis, G; Ngo, FQ | 1 |
| Hsiao, N; Lum, CT; Najarian, JS; Sutherland, DE | 1 |
| Plunkett, W | 1 |
| Tunac, JB; Underhill, M | 1 |
| Coen, DM; Fleming, HE | 1 |
| Benjamin, RS; Freireich, EJ; Keating, MJ; Plunkett, W | 1 |
| Plunkett, W; Shewach, DS | 2 |
| Coleman, MS; Siaw, MF | 1 |
| O'Brien, WJ; Taylor, JL | 1 |
| Bakay, B; Bleeker, LC; Kung, FH; Matsumoto, SS; Nyhan, WL; Yu, AL | 1 |
| Allen, LB; Cook, PD; Fingal, CM; Harris, EF; McCright, FH; Vanderslice, LK | 1 |
| Bastow, KF; Cheng, YC; Derse, DD | 1 |
| Akagi, K; Sougawa, M; Tanaka, Y; Yoshii, G | 1 |
| Benjamin, RS; Feun, LG; Freirich, EJ; Keating, M; Nowak, B; Plunkett, W | 1 |
| Agarwal, RP; Kufe, DW; Major, PP | 1 |
| Falletta, JM; Hershfield, MS; Kinney, TR; Koller, CA; Kredich, NM; Kurtzberg, J; Mitchell, BS | 1 |
| Cass, CE; Phillips, JR; Selner, M | 1 |
| Gorecki, P; Lum, CT; Matas, AJ; Najarian, JS; Payne, WD; Sutherland, DE | 1 |
| Coleman, MS; Deibel, MR; Hutton, JJ | 1 |
| Christian, R; Lee, SH; Sartorelli, AC; Thomas, LK; Unger, FM | 1 |
| Balcerzak, SP; Coleman, MS; Gray, DP; Grever, MR; Siaw, MF | 1 |
| Agarwal, RP; Blatt, J; Holcenberg, J; Lipton, JM; Miser, J; Poplack, DG; Reaman, GH; Sallan, S | 1 |
| Juliusson, G | 1 |
| Dighiero, G | 2 |
| Gollard, R; Lee, TC; Piro, LD; Saven, A | 1 |
| Byrd, JC; Diehl, LF; Freiman, J; Hertler, AA; Kweder, SL; Weiss, RB | 1 |
| Hiddemann, W; Pott-Hoeck, C | 1 |
| Hakimian, D; Tallman, MS | 1 |
| Estey, EH; Jaiyesimi, IA; Kantarjian, HM | 1 |
| Benner, A; Bentz, M; Cabot, G; Coy, J; Diehl, D; Döhner, H; Fischer, K; Galle, PR; Hansen, K; Hunstein, W; Lichter, P; Poustka, A; Schlenk, R; Stilgenbauer, S; Volkmann, M | 1 |
| Piro, LD; Saven, A | 2 |
| Saven, A | 1 |
| Cheson, BD; Foss, FM; Sorensen, JM; Vena, DA | 1 |
| Bendandi, M; Buzzi, M; Farabegoli, P; Martinelli, G; Ottaviani, E; Salvucci, M; Tosi, P; Visani, G; Zaccaria, A; Zinzani, PL | 1 |
| Beran, M; Estey, E; Kantarjian, H; Keating, MJ; Koller, C; O'Brien, S; Robertson, LB | 1 |
| Bapat, A; Goldberg, J; Goldman, N; Gordon, R; Gryn, J | 1 |
| Johnson, SA | 2 |
| Adam, Z; Hejlová, N; Vorlícek, J | 1 |
| Gandhi, V; Plunkett, W | 1 |
| Beran, M; Cortes, J; Kantarjian, H; Keating, M; Koller, C; O'Brien, S; Talpaz, M | 1 |
| Bergmann, L | 1 |
| Petryshyn, RA; Slomiany, DJ; Woldehawariat, G | 1 |
| Catovsky, D; Dyer, MJ; Emmett, E; Hale, G; Kelsey, SM; Mackay, HJ; Newland, AC; Thornton, P; Waldmann, H | 1 |
| Bolam, S; Orchard, JA; Oscier, DG | 1 |
| Christopherson, RI; Mulligan, SP; Szabados, E; Wilson, PK | 1 |
| Flandrin, G; Maloisel, F; Troussard, X | 1 |
| Machaczka, M; Rucińska, M; Skotnicki, AB; Załuska, A | 1 |
| Barrett, J; Cheson, BD; Freidlin, B; Vena, DA | 1 |
| Honma, Y; Niitsu, N; Umeda, M | 1 |
| Bosanquet, AG; Bosanquet, MI | 1 |
| Catovsky, D; Dearden, CE; Matutes, E | 1 |
| Beer, M; Byrd, JC; Grever, MR; Lucas, MA; Waselenko, JK | 1 |
| Foss, FM | 1 |
| Honma, Y; Kasukabe, T; Niitsu, N; Okabe-Kado, J; Umeda, M; Yamamoto-Yamaguchi, Y | 1 |
| Honma, Y; Niitsu, N | 1 |
| Johnson, SA; Thomas, W | 1 |
| Weiss, MA | 1 |
| Owen, RG | 1 |
| Bashey, A | 1 |
| Itälä, M; Remes, K | 1 |
| Glasmacher, A; Gorschlüter, M; Mey, U; Pralle, H; Schmidt-Wolf, I; Strehl, J; Ziske, C | 1 |
| Aliff, TB; Frankel, SR; Horgan, D; Jurcic, JG; Kossman, SE; Lamanna, N; Maslak, PG; Scheinberg, DA; Weiss, MA | 1 |
| Robak, T | 1 |
| Pettitt, AR | 1 |
| Spiers, AS | 1 |
| Gartenhaus, RB; Nabhan, C; Tallman, MS | 1 |
| Christopherson, RI; Mulligan, SP; Wilson, PK | 1 |
| Lamanna, N; Weiss, M | 1 |
| Chang, AS; Chen, J; Chi, MM; Downs, SM; Hardie, DG; Hudson, E; Moley, KH | 1 |
| Culligan, DJ; Johnston, PW; Milner, BJ; Mittal, S | 1 |
| Kay, NE | 1 |
| Bohlius, J; Greil, R; Pall, G; Richards, S; Schwarzer, G; Steurer, M | 2 |
| Aribi, A; Faderl, S; Ferrajoli, A; Huh, Y; Kantarjian, H; Keating, M; O'brien, S; Ravandi, F; Wierda, W | 1 |
| Robak, P; Robak, T | 1 |
| Christian, BA; Lin, TS | 1 |
| Lamanna, N; Sauter, C; Weiss, MA | 1 |
| Kay, NE; Lamanna, N | 1 |
| Amarnath, S; Buxhoeveden, N; Felizardo, TC; Foley, J; Fowler, DH; Mariotti, J; Massey, PR; Mossoba, ME; Ryan, K; Taylor, J | 1 |
| Asmar, L; Boehm, KA; Di Bella, N; Hyman, W; Lyons, RM; Reynolds, C; Richards, DA; Robbins, GJ; Vellek, M; Zhan, F | 1 |
| Foltynski, P; Ladyzynski, P; Molik, M | 1 |
| Hogan, JJ; Weiss, BM | 1 |
| Chen, W; Chen, X; Deng, Z; Gao, Y; Li, YQ; Ma, H; Qi, J; Wan, D; Wang, G; Wang, T; Wu, P; Xu, G; Zhu, J | 1 |
| Dimitrova, D; Kanakry, JA | 1 |
49 review(s) available for vidarabine and pentostatin
| Article | Year |
|---|---|
New antimetabolites in the treatment of human malignancies.
Topics: Animals; Antimetabolites, Antineoplastic; Cladribine; Clinical Trials as Topic; Drugs, Investigational; Forecasting; Humans; Immunosuppression Therapy; Leukemia; Lymphoma; Pentostatin; Purines; Vidarabine | 1992 |
A clinical update on chronic lymphocytic leukemia. II. Critical analysis of current chemotherapeutic modalities.
Topics: 2-Chloroadenosine; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Transplantation; Chlorambucil; Deoxyadenosines; Dose-Response Relationship, Drug; Histocompatibility Testing; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Pentostatin; Prednisone; Prognosis; Survival Rate; Vidarabine | 1992 |
New purine analogues for the treatment of chronic B-cell malignancies.
Topics: 2-Chloroadenosine; Antineoplastic Agents; Cladribine; Clinical Trials as Topic; Deoxyadenosines; Leukemia, Lymphocytic, Chronic, B-Cell; Pentostatin; Vidarabine | 1991 |
Immunological and genetic abnormalities in chronic lymphocytic leukaemia. Impact of the purine analogues.
Topics: Antineoplastic Agents; Chromosome Aberrations; Chromosomes, Human, Pair 12; Chromosomes, Human, Pair 13; Cladribine; Humans; Immunity, Cellular; Leukemia, Lymphocytic, Chronic, B-Cell; Pentostatin; Vidarabine | 1994 |
Potential immunological action of purine nucleoside analogues.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cladribine; Humans; Immunosuppressive Agents; Leukemia; Pentostatin; Purine Nucleosides; Vidarabine | 1994 |
The optimal management of hairy cell leukaemia.
Topics: Antineoplastic Agents; Cladribine; Combined Modality Therapy; Granulocyte Colony-Stimulating Factor; Humans; Interferons; Leukemia, Hairy Cell; Pentostatin; Splenectomy; Vidarabine | 1995 |
Infectious and immunosuppressive complications of purine analog therapy.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cladribine; Humans; Immune Tolerance; Infections; Pentostatin; Purines; Vidarabine | 1995 |
Purine analogs in the treatment of low-grade lymphomas and chronic lymphocytic leukemias.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Cladribine; Humans; Leukemia, Hairy Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin; Pentostatin; Purines; Vidarabine | 1995 |
Purine nucleoside analogs: emerging roles in indolent lymphoproliferative disorders.
Topics: Antineoplastic Agents; Cladribine; Clinical Trials as Topic; Drug Resistance; Humans; Lymphoproliferative Disorders; Pentostatin; Purine Nucleosides; Vidarabine | 1995 |
Advances in therapy for hairy cell leukemia. A review.
Topics: 2-Chloroadenosine; Deoxyadenosines; Forecasting; Granulocyte Colony-Stimulating Factor; Humans; Interferons; Leukemia, Hairy Cell; Male; Pentostatin; Splenectomy; Vidarabine | 1993 |
The newer purine analogs. Significant therapeutic advance in the management of lymphoid malignancies.
Topics: Antineoplastic Agents; Cladribine; Humans; Leukemia; Lymphoma; Pentostatin; Vidarabine | 1993 |
Purine analogs in lymphoproliferative disorders.
Topics: Antineoplastic Agents; Cladribine; Humans; Leukemia; Lymphoma, Non-Hodgkin; Lymphoproliferative Disorders; Multiple Myeloma; Pentostatin; Vidarabine | 1993 |
Comparative efficacy of the newer nucleosides (fludarabine, 2'-deoxycoformycin, and 2-chlorodeoxyadenosine) in the treatment of indolent lymphoid malignancies.
Topics: Antineoplastic Agents; Cladribine; Clinical Trials as Topic; Humans; Leukemia; Lymphoma; Molecular Structure; Pentostatin; Purine Nucleosides; Vidarabine | 1993 |
Neurotoxicity of purine analogs: a review.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Female; Humans; Male; Middle Aged; Nervous System; Nervous System Diseases; Pentostatin; Purine Nucleosides; Vidarabine | 1994 |
Nucleoside analogs in treatment of chronic lymphocytic leukemia.
Topics: Antineoplastic Agents; Cladribine; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Pentostatin; Survival Rate; Vidarabine | 1993 |
Purine analogues in the management of lymphoproliferative diseases.
Topics: Antineoplastic Agents; Cladribine; Humans; Lymphoproliferative Disorders; Pentostatin; Vidarabine | 1996 |
[Treatment of chronic lymphatic leukemia].
Topics: Antineoplastic Agents; Cladribine; Humans; Interferon-alpha; Leukemia, Lymphocytic, Chronic, B-Cell; Pentostatin; Prognosis; Vidarabine | 1996 |
2-Chlorodeoxyadenosine treatment of lymphoma.
Topics: Adenosine Deaminase; Antimetabolites, Antineoplastic; Antineoplastic Agents; Cladribine; Humans; Lymphoma; Lymphoma, B-Cell; Lymphoma, T-Cell, Cutaneous; Pentostatin; Vidarabine; Waldenstrom Macroglobulinemia | 1996 |
Pharmacology of purine nucleoside analogues.
Topics: Animals; Antineoplastic Agents; Cladribine; Hematologic Neoplasms; Humans; Pentostatin; Purine Nucleosides; Vidarabine | 1996 |
Adverse and beneficial immunological effects of purine nucleoside analogues.
Topics: Animals; Antineoplastic Agents; Cladribine; Humans; Immunosuppressive Agents; Leukemia, Lymphocytic, Chronic, B-Cell; Pentostatin; Purine Nucleosides; Vidarabine | 1996 |
Perspectives on purine analogues.
Topics: Antineoplastic Agents; Cladribine; Forecasting; Humans; Leukemia; Pentostatin; Purines; Vidarabine | 1996 |
Present status of purine analogs in the therapy of chronic lymphocytic leukemias.
Topics: Antineoplastic Agents; Cladribine; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Pentostatin; Prognosis; Recurrence; Remission Induction; Vidarabine | 1997 |
Therapy for previously untreated chronic lymphocytic leukemia: a reevaluation.
Topics: Antineoplastic Agents; Cladribine; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Pentostatin; Randomized Controlled Trials as Topic; Vidarabine | 1998 |
Hairy cell leukemia. What is new forty years after the first description?
Topics: 2-Chloroadenosine; Antigens, CD; Antimetabolites, Antineoplastic; Antineoplastic Agents; B-Lymphocytes; Bone Marrow; Clinical Trials as Topic; Deoxyadenosines; Humans; Immunologic Factors; Interferon Type I; Leukemia, Hairy Cell; Neoplasm Proteins; Neoplasms, Second Primary; Neoplastic Stem Cells; Pentostatin; Receptors, Antigen, T-Cell, gamma-delta; Recombinant Proteins; Splenectomy; Vidarabine | 1998 |
[Hairy cell leukemia--a potentially curable malignancy. Selected aspects of purine analog therapy].
Topics: Antineoplastic Agents; Cladribine; Humans; Leukemia, Hairy Cell; Neoplasm, Residual; Pentostatin; Remission Induction; Splenectomy; Vidarabine | 1998 |
Pentostatin (Nipent) and chlorambucil with granulocyte-macrophage colony-stimulating factor support for patients with previously untreated, treated, and fludarabine-refractory B-cell chronic lymphocytic leukemia.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Clinical Trials, Phase II as Topic; Disease-Free Survival; Drug Resistance, Neoplasm; Drug Synergism; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Immunosuppressive Agents; Leukemia, B-Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Pentostatin; Remission Induction; Vidarabine | 2000 |
Combination therapy with purine nucleoside analogs.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Deoxyadenosines; Disease-Free Survival; Dose-Response Relationship, Drug; Female; Humans; Interferons; Lymphoma, B-Cell; Lymphoma, T-Cell; Male; Middle Aged; Pentostatin; Purine Nucleosides; Treatment Outcome; Vidarabine | 2000 |
Vidarabine and 2-deoxycoformycin as antileukemic agents against monocytic leukemia.
Topics: Animals; Antibiotics, Antineoplastic; Antimetabolites; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Dose-Response Relationship, Drug; Humans; Leukemia, Monocytic, Acute; Pentostatin; Vidarabine | 2000 |
Therapeutic potential of purine analogue combinations in the treatment of lymphoid malignancies.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cladribine; Clinical Trials as Topic; Drug Synergism; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin; Pentostatin; Purines; Vidarabine | 2000 |
Novel treatment strategies in chronic lymphocytic leukemia.
Topics: Antibodies, Monoclonal; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cladribine; Cyclophosphamide; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Pentostatin; Randomized Controlled Trials as Topic; Sex Factors; Vidarabine | 2001 |
Nucleoside analogues in the treatment of haematological malignancies.
Topics: Antimetabolites, Antineoplastic; Arabinonucleosides; Biological Transport; Cladribine; Clinical Trials as Topic; Cytarabine; Cytosine; Deoxycytidine; Dioxolanes; Economics, Pharmaceutical; Gemcitabine; Guidelines as Topic; Hematologic Neoplasms; Humans; Molecular Structure; Nucleosides; Pentostatin; Vidarabine | 2001 |
Treatment options in Waldenström's macroglobulinaemia: the role of the purine analogues.
Topics: Alkylating Agents; Antimetabolites; Chlorambucil; Cladribine; Clinical Trials as Topic; Drug Resistance; Drug Therapy, Combination; Guidelines as Topic; Humans; Middle Aged; Pentostatin; Plasmapheresis; Purine Nucleosides; Quality of Life; Vidarabine; Waldenstrom Macroglobulinemia | 2001 |
Immunosuppression with limited toxicity: the characteristics of nucleoside analogs and anti-lymphocyte antibodies used in non-myeloablative hematopoietic cell transplantation.
Topics: Animals; Antibodies, Monoclonal; Antilymphocyte Serum; Cladribine; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Pentostatin; Transplantation, Homologous; Vidarabine | 2002 |
[Nucleoside analogues--new drugs for the treatment of lymphatic cancers].
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Cladribine; Clinical Trials as Topic; Humans; Leukemia, Lymphoid; Lymphoma; Nucleosides; Pentostatin; Vidarabine | 2001 |
Advances in the treatment of hairy-cell leukaemia.
Topics: Antibiotics, Antineoplastic; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD; Antigens, Differentiation, B-Lymphocyte; Antineoplastic Agents; Cell Adhesion Molecules; Cladribine; Humans; Interferon-alpha; Lectins; Leukemia, Hairy Cell; Neoplasm, Residual; Neoplasms, Second Primary; Pancytopenia; Pentostatin; Receptors, Interleukin-2; Rituximab; Sialic Acid Binding Ig-like Lectin 2; Spleen; Splenectomy; Splenomegaly; Treatment Outcome; Vidarabine | 2003 |
Purine nucleoside analogues in the treatment of myleoid leukemias.
Topics: Acute Disease; Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cladribine; Clinical Trials as Topic; Cytarabine; Drug Synergism; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Humans; Infant; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Male; Middle Aged; Pentostatin; Peripheral Blood Stem Cell Transplantation; Remission Induction; Salvage Therapy; Transplantation Conditioning; Transplantation, Autologous; Transplantation, Homologous; Treatment Outcome; Vidarabine | 2003 |
Mechanism of action of purine analogues in chronic lymphocytic leukaemia.
Topics: Antineoplastic Agents; Apoptosis; Caspases; Cell Division; Cladribine; DNA Damage; Drug Resistance, Neoplasm; Drug Synergism; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Pentostatin; Phosphorylation; Tumor Suppressor Protein p53; Vidarabine | 2003 |
Deoxycoformycin (pentostatin): clinical pharmacology, role in the chemotherapy of cancer, and use in other diseases.
Topics: Adenosine Deaminase Inhibitors; Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Drug Synergism; Enzyme Inhibitors; Forecasting; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Kidney Diseases; Mice; Molecular Structure; Neoplasm Proteins; Nervous System Diseases; Pentostatin; Vidarabine | 1996 |
Purine nucleoside analogues and combination therapies in B-cell chronic lymphocytic leukemia: dawn of a new era.
Topics: Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antibodies, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Pentostatin; Rituximab; Vidarabine | 2004 |
Purine analogs in leukemia.
Topics: Antineoplastic Agents; Cladribine; Humans; Leukemia; Pentostatin; Purines; Stem Cell Transplantation; Vidarabine | 2004 |
Purine analogue-based chemotherapy regimens for patients with previously untreated B-chronic lymphocytic leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Pentostatin; Purine Nucleosides; Risk Assessment; Treatment Outcome; Vidarabine | 2006 |
Single-agent purine analogues for the treatment of chronic lymphocytic leukaemia: a systematic review and meta-analysis.
Topics: Anemia, Hemolytic; Antineoplastic Agents; Cladribine; Disease-Free Survival; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Pentostatin; Randomized Controlled Trials as Topic; Survival Analysis; Treatment Outcome; Vidarabine | 2006 |
Purine antagonists for chronic lymphocytic leukaemia.
Topics: Antineoplastic Agents; Chlorambucil; Cladribine; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Pentostatin; Randomized Controlled Trials as Topic; Vidarabine | 2006 |
Current treatment options in prolymphocytic leukemia.
Topics: Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antibodies, Neoplasm; Cladribine; Drug Therapy; Humans; Leukemia, Prolymphocytic; Pentostatin; Purine Nucleosides; Rituximab; Splenectomy; Stem Cell Transplantation; Vidarabine | 2007 |
Antibody therapy for chronic lymphocytic leukemia.
Topics: Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antibodies, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Disease Progression; Disease-Free Survival; Drugs, Investigational; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Mutation; Pentostatin; Rituximab; Vidarabine | 2008 |
Pentostatin in chronic lymphocytic leukemia.
Topics: Adenosine Deaminase Inhibitors; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Pentostatin; Vidarabine | 2008 |
Pentostatin treatment combinations in chronic lymphocytic leukemia.
Topics: Age Factors; Aged; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antibodies, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase II as Topic; Cyclophosphamide; Drug Administration Schedule; Forecasting; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Middle Aged; Mitoxantrone; Multicenter Studies as Topic; Pentostatin; Rituximab; Salvage Therapy; Treatment Outcome; Vidarabine | 2009 |
A network meta-analysis of progression free survival and overall survival in first-line treatment of chronic lymphocytic leukemia.
Topics: Age Factors; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bayes Theorem; Bendamustine Hydrochloride; Chlorambucil; Cyclophosphamide; Disease-Free Survival; Humans; Kaplan-Meier Estimate; Leukemia, Lymphocytic, Chronic, B-Cell; Markov Chains; Nitrogen Mustard Compounds; Pentostatin; Physical Fitness; Proportional Hazards Models; Randomized Controlled Trials as Topic; Rituximab; Vidarabine | 2015 |
Bridging the Divide: An Onco-Nephrologic Approach to the Monoclonal Gammopathies of Renal Significance.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Bortezomib; Cyclophosphamide; Dexamethasone; Humans; Immunoglobulins; Immunosuppressive Agents; Kidney Diseases; Lenalidomide; Melphalan; Oligopeptides; Paraproteinemias; Pentostatin; Rituximab; Thalidomide; Vidarabine | 2016 |
6 trial(s) available for vidarabine and pentostatin
| Article | Year |
|---|---|
Lack of significant activity of 2'-deoxycoformycin alone or in combination with adenine arabinoside in relapsed childhood acute lymphoblastic leukemia. A randomized phase II trial from the Childrens Cancer Study Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Drug Synergism; Humans; Immunophenotyping; Pentostatin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Vidarabine | 1992 |
Inhibition of adenosine deaminase to increase the antitumor activity of adenine nucleoside analogues.
Topics: Adenine; Adenosine Deaminase Inhibitors; Adult; Animals; Carcinoma, Ehrlich Tumor; Clinical Trials as Topic; Coformycin; DNA; Drug Evaluation; Drug Synergism; Humans; Leukemia P388; Leukemia, Experimental; Leukemia, Lymphoid; Male; Mice; Nucleoside Deaminases; Pentostatin; Thymidine; Vidarabine | 1985 |
Modulation of arabinosyladenine metabolism by 2'-deoxycoformycin in the therapy of human acute leukemia.
Topics: Adenosine Deaminase; Antineoplastic Agents; Clinical Trials as Topic; Coformycin; Erythrocytes; Humans; Kinetics; Leukemia; Nucleoside Deaminases; Pentostatin; Ribonucleosides; Vidarabine | 1984 |
Treatment of chronic myelogenous leukemia with nucleoside analogs deoxycoformycin and fludarabine.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Drug Administration Schedule; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukocyte Count; Middle Aged; Pentostatin; Vidarabine | 1997 |
T-cell large granular lymphocytic (T-LGL) leukemia: experience in a single institution over 8 years.
Topics: Adult; Aged; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Agents; Cyclosporine; Female; Flow Cytometry; Humans; Immunophenotyping; Leukemia, Lymphoid; Leukemia, T-Cell; Male; Middle Aged; Pentostatin; Retrospective Studies; Vidarabine | 2007 |
A Phase III trial of fludarabine, cyclophosphamide, and rituximab vs. pentostatin, cyclophosphamide, and rituximab in B-cell chronic lymphocytic leukemia.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Pentostatin; Rituximab; Treatment Outcome; Vidarabine | 2012 |
58 other study(ies) available for vidarabine and pentostatin
| Article | Year |
|---|---|
Structure-based design and synthesis of non-nucleoside, potent, and orally bioavailable adenosine deaminase inhibitors.
Topics: Adenosine Deaminase Inhibitors; Administration, Oral; Animals; Biological Availability; Crystallography, X-Ray; Dogs; Drug Design; Humans; Imidazoles; In Vitro Techniques; Microsomes, Liver; Models, Molecular; Molecular Structure; Naphthalenes; Rats; Structure-Activity Relationship | 2004 |
Rational design of non-nucleoside, potent, and orally bioavailable adenosine deaminase inhibitors: predicting enzyme conformational change and metabolism.
Topics: Adenosine Deaminase; Adenosine Deaminase Inhibitors; Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Benzoxazoles; Biological Availability; Crystallography, X-Ray; Dogs; Drug Design; Humans; Imidazoles; In Vitro Techniques; Mice; Mice, SCID; Microsomes, Liver; Models, Molecular; Protein Conformation; Rats; Structure-Activity Relationship; U937 Cells; Xenograft Model Antitumor Assays | 2005 |
The purine analogs--a therapeutic beauty contest.
Topics: 2-Chloroadenosine; Antineoplastic Agents; Cladribine; Deoxyadenosines; Humans; Leukemia; Lymphoma, Non-Hodgkin; Pentostatin; Vidarabine | 1992 |
The purine analogs--a therapeutic beauty contest.
Topics: 2-Chloroadenosine; Antineoplastic Agents; Cladribine; Deoxyadenosines; Humans; Leukemia; Pentostatin; Vidarabine | 1992 |
Pentostatin and 2-chlorodeoxyadenosine for hairy-cell leukemia.
Topics: 2-Chloroadenosine; Antineoplastic Agents; Cladribine; Clinical Trials as Topic; Deoxyadenosines; Humans; Leukemia, Hairy Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin; Pentostatin; Vidarabine | 1992 |
New drugs in the treatment of chronic lymphocytic leukemia.
Topics: Antineoplastic Agents; Cladribine; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Pentostatin; Vidarabine | 1992 |
Potentiation of growth-inhibitory activity of 9-beta-D-arabinofuranosyladenine by 2'-deoxycoformycin in human cultured cell lines derived from leukemias and lymphomas.
Topics: Adenosine Deaminase; Antineoplastic Agents; Cell Division; Coformycin; Drug Stability; Drug Synergism; Humans; Leukemia; Lymphoma; Pentostatin; Ribonucleosides; Tumor Cells, Cultured; Vidarabine | 1989 |
Activity of (+)-cyclaradine (Sch 31172) against herpes simplex virus in vitro and in vivo.
Topics: Acyclovir; Animals; Cell Line; Coformycin; Female; Guinea Pigs; Herpes Simplex; Humans; Pentostatin; Simplexvirus; Vero Cells; Vidarabine | 1987 |
Induction of complete remission in T-cell acute lymphoblastic leukemia with deoxycoformycin (dcf) and 9-beta-D-arabinofuranosyladenine (ara-A).
Topics: Adult; Antigens, Surface; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Survival; Coformycin; Drug Administration Schedule; Humans; Leukemia, Lymphoid; Male; Pentostatin; Ribonucleosides; T-Lymphocytes; Vidarabine | 1986 |
Therapy with 9-beta-D-arabinofuranosyladenine (ARA-A) and 2'-deoxycoformycin increases the ARA-A content of ocular tissues.
Topics: Animals; Arabinonucleosides; Chromatography; Coformycin; Eye; Keratitis, Dendritic; Pentostatin; Rabbits; Ribonucleosides; Vidarabine | 1986 |
Determination of S-adenosylhomocysteine in tissues following pharmacological inhibition of S-adenosylhomocysteine catabolism.
Topics: Adenosylhomocysteinase; Animals; Coformycin; Freezing; Homocysteine; Hydrolases; Mice; Pentostatin; Ribonucleosides; S-Adenosylhomocysteine; Time Factors; Tissue Distribution; Vidarabine | 1986 |
Inhibitor of 2', 5'-oligoadenylate synthetase induced in human T lymphoblastoid cell line treated with deoxyadenosine, deoxycoformycin and interferon.
Topics: 2',5'-Oligoadenylate Synthetase; Adenosine; Cell Line; Coformycin; Deoxyadenine Nucleotides; Deoxyadenosines; Enzyme Induction; Homocysteine; Humans; Interferon Type I; Pentostatin; Ribonucleosides; T-Lymphocytes; Vidarabine | 1986 |
Enhancement of biotinidase activity in mouse serum by inhibitors of methylation.
Topics: Adenine; Adenosine; Amidohydrolases; Animals; Biotinidase; Coformycin; Ethionine; Female; Liver; Methylation; Mice; Pentostatin; Vidarabine | 1987 |
Adechlorin, a new adenosine deaminase inhibitor containing chlorine production, isolation and properties.
Topics: Actinomycetales; Adenosine Deaminase Inhibitors; Animals; Chemical Phenomena; Chemistry; Chlorine; Kinetics; Magnetic Resonance Spectroscopy; Mice; Nucleoside Deaminases; Nucleosides; Pentostatin; Vidarabine | 1985 |
Effects of adenosine deaminase inhibitor 2'-deoxycoformycin on the repair and expression of potentially lethal damage sensitive to beta-araA.
Topics: Adenosine Deaminase Inhibitors; Animals; Cell Line; Cell Survival; Coformycin; Cricetinae; Cricetulus; DNA Repair; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; In Vitro Techniques; Nucleoside Deaminases; Pentostatin; Ribonucleosides; Vidarabine | 1985 |
Relevance of adenosine deaminase to organ transplantation.
Topics: Adenine; Adenosine Deaminase; Adenosine Deaminase Inhibitors; Animals; Coformycin; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Nucleoside Deaminases; Pentostatin; Skin Transplantation; Splenectomy; T-Lymphocytes; Vidarabine | 1985 |
2'-Chloropentostatin: discovery, fermentation and biological activity.
Topics: Actinomycetales; Adenosine Deaminase Inhibitors; Anti-Bacterial Agents; Biological Assay; Coformycin; Enterococcus faecalis; Fermentation; Nucleosides; Pentostatin; Vidarabine | 1985 |
Herpes simplex virus mutants resistant to arabinosyladenine in the presence of deoxycoformycin.
Topics: Animals; Coformycin; DNA-Directed DNA Polymerase; Drug Resistance, Microbial; Genetic Markers; Mutation; Pentostatin; Ribonucleosides; Simplexvirus; Vidarabine | 1984 |
Modulation of 9-beta-D-arabinofuranosyladenine 5'-triphosphate and deoxyadenosine triphosphate in leukemic cells by 2'-deoxycoformycin during therapy with 9-beta-D-arabinofuranosyladenine.
Topics: Adult; Arabinonucleotides; Cell Line; Chromatography, High Pressure Liquid; Coformycin; Deoxyadenine Nucleotides; DNA; Drug Therapy, Combination; Humans; Leukemia, Lymphoid; Male; Pentostatin; Ribonucleosides; Vidarabine; Vidarabine Phosphate | 1982 |
Correlation of cytotoxicity with total intracellular exposure to 9-beta-D-arabinofuranosyladenine 5'-triphosphate.
Topics: Animals; Arabinonucleotides; Cell Line; Cell Survival; Coformycin; Cricetinae; Female; Kinetics; Ovary; Pentostatin; Vidarabine; Vidarabine Phosphate | 1982 |
Effect of 2'-deoxycoformycin on the inhibition of deoxyribonucleic acid synthesis by 9-beta-D-arabinofuranosyladenine 5'-triphosphate.
Topics: Adenosine Deaminase Inhibitors; Animals; Arabinonucleotides; Cells, Cultured; Coformycin; Cricetinae; Cricetulus; Deamination; DNA; Drug Interactions; Female; Nucleoside Deaminases; Pentostatin; Phosphorylation; Ribonucleosides; Thymidine; Time Factors; Vidarabine; Vidarabine Phosphate | 1982 |
In vitro metabolism of deoxycoformycin in human T lymphoblastoid cells. Phosphorylation of deoxycoformycin and incorporation into cellular DNA.
Topics: Adenosine Deaminase Inhibitors; Adenosine Kinase; Chromatography, High Pressure Liquid; Coformycin; Deoxyadenine Nucleotides; Deoxyadenosines; Deoxycytidine Kinase; DNA; Humans; Nucleoside Deaminases; Pentostatin; Phosphorylation; Ribonucleosides; RNA; T-Lymphocytes; Vidarabine | 1984 |
Chemotherapy of herpetic keratitis induced by acyclovir-resistant strains of herpes simplex virus type 1.
Topics: Acyclovir; Animals; Antiviral Agents; Coformycin; Drug Resistance, Microbial; Drug Therapy, Combination; Guanine; Keratitis, Dendritic; Mutation; Pentostatin; Rabbits; Simplexvirus; Thymidine Kinase; Trifluridine; Vidarabine | 1982 |
Biochemical correlates of the differential sensitivity of subtypes of human leukemia to deoxyadenosine and deoxycoformycin.
Topics: Adenosine Deaminase; Adolescent; Deoxyadenine Nucleotides; Deoxyadenosines; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Leukocytes; Lymphocytes; Lymphoma; Male; Nucleotidases; Pentostatin; Thymidine; Vidarabine | 1982 |
Evaluation of the anti-herpesvirus drug combinations: virazole plus arabinofuranosylhypoxanthine and virazole plus arabinofuranosyladenine.
Topics: Animals; Arabinonucleosides; Cell Line; Cell Survival; Coformycin; Cricetinae; Dose-Response Relationship, Drug; Drug Antagonism; Drug Evaluation, Preclinical; Drug Synergism; Humans; Pentostatin; Ribavirin; Ribonucleosides; Simplexvirus; Vidarabine | 1982 |
Susceptibility of phosphonoformic acid-resistant herpes simplex virus variants to arabinosylnucleosides and aphidicolin.
Topics: Antiviral Agents; Aphidicolin; Arabinonucleosides; Coformycin; Diterpenes; DNA-Directed DNA Polymerase; Drug Resistance, Microbial; Foscarnet; Pentostatin; Phosphonoacetic Acid; Simplexvirus; Thymidine; Thymidine Kinase; Vidarabine | 1983 |
[Problems of antineoplastic effects by PLDR (potential lethal damage repair) inhibitor--pharmacokinetics].
Topics: Adenocarcinoma; Aged; Animals; Chromatography, High Pressure Liquid; Coformycin; Combined Modality Therapy; Drug Synergism; Female; Humans; Kinetics; Lung Neoplasms; Mice; Mice, Inbred BALB C; Pentostatin; Rabbits; Rats; Rats, Inbred F344; Ribonucleosides; Vidarabine | 1984 |
Clinical pharmacology of arabinofuranosyladenine in combination with deoxycoformycin.
Topics: Adenosine; Adult; Antineoplastic Agents; Coformycin; Deoxyadenosines; Drug Administration Schedule; Drug Therapy, Combination; Half-Life; Humans; Kinetics; Leukemia; Male; Pentostatin; Ribonucleosides; Vidarabine | 1983 |
S-adenosylhomocysteine catabolism and basis for acquired resistance during treatment of T-cell acute lymphoblastic leukemia with 2'-deoxycoformycin alone and in combination with 9-beta-D-arabinofuranosyladenine.
Topics: Acute Disease; Adenosine; Adult; Coformycin; Deoxyadenosines; Drug Resistance; Drug Therapy, Combination; Erythrocytes; Homocysteine; Humans; Leukemia, Lymphoid; Lymphocytes; Male; Pentostatin; Ribonucleosides; S-Adenosylhomocysteine; Time Factors; Vidarabine | 1983 |
Resistance to 9-beta-D-arabinofuranosyladenine in cultured leukemia L 1210 cells.
Topics: Adenosine Kinase; Animals; Cell Division; Coformycin; DNA Replication; Drug Resistance; Leukemia L1210; Mice; Pentostatin; Tubercidin; Vidarabine | 1983 |
Prolongation of mouse and rat pancreatic islet cell allografts by adenosine deaminase inhibitors and adenine arabinoside.
Topics: Animals; Coformycin; Diabetes Mellitus, Experimental; Female; Graft Survival; Immunosuppressive Agents; Islets of Langerhans Transplantation; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Pentostatin; Rats; Rats, Inbred Lew; Ribonucleosides; Transplantation, Homologous; Vidarabine | 1980 |
Effect of adenosine deaminase inhibitors on the apparent rate of phosphorylation of deoxyadenosine.
Topics: Adenine; Adenosine Deaminase Inhibitors; Cell Line; Coformycin; Deoxyadenosines; Enzyme Inhibitors; Humans; Leukemia, Lymphoid; Nucleoside Deaminases; Pentostatin; Phosphorylation; Vidarabine | 1981 |
Comparative antineoplastic activity against P388 leukemia of 9-beta-D-arabinofuranosyladenine (araA) and 9-beta-(2'-azido-2'-deoxy-D-arabinofuranosyl) adenine (arazide).
Topics: Adenosine Deaminase Inhibitors; Animals; Antineoplastic Agents; Cells, Cultured; Coformycin; DNA, Neoplasm; Drug Therapy, Combination; Leukemia P388; Leukemia, Experimental; Mice; Pentostatin; Vidarabine | 1981 |
2'-deoxycoformycin (DCF) and 9-beta-D-arabinofuranosyladenine (Ara-A) in the treatment of refractory acute myelocytic leukemia.
Topics: Adenosine Deaminase; Adult; Coformycin; Deoxyribonucleotides; Drug Evaluation; Drug Therapy, Combination; Humans; Leukemia, Myeloid, Acute; Male; Nucleosides; Pentostatin; Ribonucleosides; Ribonucleotides; Vidarabine | 1982 |
Reactivation of S-adenosylhomocysteine hydrolase activity in cells exposed to 9-beta-D-arabinofuranosyladenine.
Topics: Adenosine Deaminase; Adenosine Deaminase Inhibitors; Adenosylhomocysteinase; Animals; Cell Line; Cells, Cultured; Coformycin; Enzyme Activation; Fibroblasts; Homocysteine; Hydrolases; Inosine; Liver; Mice; Pentostatin; Plasmacytoma; Rats; Vidarabine | 1982 |
Clinical pharmacology of 9-beta-D-arabinofuranosyladenine in combination with 2'-deoxycoformycin.
Topics: Adolescent; Adult; Arabinonucleosides; Child, Preschool; Coformycin; Drug Evaluation; Drug Therapy, Combination; Female; Half-Life; Humans; Hypoxanthines; Kinetics; Leukemia, Lymphoid; Male; Pentostatin; Ribonucleosides; Vidarabine | 1982 |
Fatal recurrence of autoimmune hemolytic anemia following pentostatin therapy in a patient with a history of fludarabine-associated hemolytic anemia.
Topics: Anemia, Hemolytic; Antineoplastic Agents; Autoimmune Diseases; Fatal Outcome; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Pentostatin; Recurrence; Vidarabine | 1995 |
p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias.
Topics: Adult; Aged; Aged, 80 and over; Base Sequence; Chromosome Aberrations; Chromosomes, Human, Pair 17; Female; Gene Deletion; Genes, p53; Humans; In Situ Hybridization, Fluorescence; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Molecular Sequence Data; Pentostatin; Polymorphism, Single-Stranded Conformational; Survival Rate; Vidarabine | 1995 |
Apoptosis induction with three nucleoside analogs on freshly isolated B-chronic lymphocytic leukemia cells.
Topics: Aged; Apoptosis; Cladribine; DNA Damage; Female; Humans; In Vitro Techniques; Interferon-alpha; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Pentostatin; Tumor Cells, Cultured; Vidarabine | 1994 |
Pentostatin increases the acute toxicity of high dose cyclophosphamide.
Topics: Adult; Animals; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Synergism; Etoposide; Fatal Outcome; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Pentostatin; Prednisone; Rats; Rats, Inbred Lew; Salvage Therapy; Shock, Cardiogenic; Ventricular Fibrillation; Vidarabine; Vincristine | 1993 |
Chemotherapeutic purine analogs alter the level of interferon-beta mRNA induced by poly I-poly C in cultured osteosarcoma cells.
Topics: Antineoplastic Agents; Cladribine; Dose-Response Relationship, Drug; eIF-2 Kinase; Gene Expression; Humans; Interferon-beta; Neoplastic Stem Cells; Pentostatin; Poly I-C; Protein Serine-Threonine Kinases; RNA, Messenger; Vidarabine | 1997 |
In vivo 'purging' of residual disease in CLL with Campath-1H.
Topics: Adult; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Neoplasm, Residual; Pentostatin; Vidarabine | 1997 |
Association of myelodysplastic changes with purine analogues.
Topics: 2-Chloroadenosine; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Deoxyadenosines; Female; Humans; Lymphoproliferative Disorders; Male; Myelodysplastic Syndromes; Pentostatin; Vidarabine | 1998 |
New prospects in the treatment of indolent lymphomas with purine analogues.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Deoxycytidine; Drug Resistance, Neoplasm; Gemcitabine; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Pentostatin; Vidarabine | 1998 |
Comparative effects of cladribine, fludarabine and pentostatin on nucleotide metabolism in T- and B-cell lines.
Topics: Adenosine Deaminase Inhibitors; Antibiotics, Antineoplastic; Antineoplastic Agents; Cell Division; Cladribine; Deoxyribonucleotides; Enzyme Inhibitors; Humans; Kinetics; Leukemia, T-Cell; Lymphoma, B-Cell; Pentostatin; Ribonucleotides; Tumor Cells, Cultured; Vidarabine | 1998 |
Second malignancies as a consequence of nucleoside analog therapy for chronic lymphoid leukemias.
Topics: Aged; Antineoplastic Agents; Cladribine; Female; Follow-Up Studies; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Neoplasms, Second Primary; Pentostatin; Vidarabine | 1999 |
Myeloid and monocytoid leukemia cells have different sensitivity to differentiation-inducing activity of deoxyadenosine analogs.
Topics: Acute Disease; Adenosine Deaminase Inhibitors; Antimetabolites, Antineoplastic; Calcitriol; Cell Differentiation; Cladribine; Deoxyadenosines; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; HL-60 Cells; Humans; K562 Cells; Leukemia, Myeloid; Monocytes; Neoplasm Proteins; Neoplastic Stem Cells; Pentostatin; Tretinoin; Tumor Cells, Cultured; U937 Cells; Vidarabine | 2000 |
Ex vivo assessment of drug response by differential staining cytotoxicity (DiSC) assay suggests a biological basis for equality of chemotherapy irrespective of age for patients with chronic lymphocytic leukaemia.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents; Chlorambucil; Cladribine; Comorbidity; Cyclophosphamide; Doxorubicin; Drug Resistance, Neoplasm; Epirubicin; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Methylprednisolone; Middle Aged; Neoplastic Stem Cells; Palliative Care; Pentostatin; Prednisolone; Prognosis; Staining and Labeling; Tumor Cells, Cultured; Vidarabine; Vincristine | 2000 |
Clinical overview of pentostatin (Nipent) use in lymphoid malignancies.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Drug Resistance, Neoplasm; Follow-Up Studies; Humans; Immunosuppressive Agents; Leukemia; Leukemia, B-Cell; Leukemia, Hairy Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Prolymphocytic; Leukemia, T-Cell; Lymphoma; Lymphoma, B-Cell; Lymphoma, T-Cell; Pentostatin; Sezary Syndrome; Survival Rate; Vidarabine | 2000 |
Antileukemic efficacy of 2-deoxycoformycin in monocytic leukemia cells.
Topics: Animals; Antibiotics, Antineoplastic; Antimetabolites; Cell Survival; Humans; Leukemia, Monocytic, Acute; Mice; Mice, Nude; Pentostatin; U937 Cells; Vidarabine | 2000 |
Pentostatin and cyclophosphamide: an effective new regimen in previously treated patients with chronic lymphocytic leukemia.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cyclophosphamide; Drug Administration Schedule; Drug Resistance; Female; Humans; Immunosuppressive Agents; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Neutropenia; Pentostatin; Thrombocytopenia; Treatment Outcome; Vidarabine | 2003 |
Metabolic response patterns of nucleotides in B-cell chronic lymphocytic leukaemias to cladribine, fludarabine and deoxycoformycin.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Humans; Ionomycin; Kinetics; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Nucleotides; Pentostatin; Prognosis; Tumor Cells, Cultured; Vidarabine | 2004 |
Fludarabine: new indication. First-line treatment of CLL: unconvincing evidence.
Topics: Antibiotics, Antineoplastic; Antimetabolites; Antineoplastic Agents, Alkylating; Chlorambucil; Clinical Trials as Topic; Drug Approval; Drug Therapy, Combination; France; Humans; Injections, Intravenous; Leukemia, Lymphocytic, Chronic, B-Cell; Middle Aged; Pentostatin; Randomized Controlled Trials as Topic; Remission Induction; Survival Rate; Treatment Outcome; Vidarabine | 2005 |
AMPK regulation of mouse oocyte meiotic resumption in vitro.
Topics: Adenosine; Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Cells, Cultured; Female; Meiosis; Mice; Mice, Inbred C57BL; Microinjections; Multienzyme Complexes; Oocytes; Pentostatin; Protein Serine-Threonine Kinases; Ribonucleotides; Rosiglitazone; Thiazolidinediones; Vidarabine | 2006 |
A case of hepatosplenic gamma-delta T-cell lymphoma with a transient response to fludarabine and alemtuzumab.
Topics: Adolescent; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Crohn Disease; Cytarabine; Epirubicin; Epstein-Barr Virus Infections; Etoposide; Fatal Outcome; Gene Rearrangement, delta-Chain T-Cell Antigen Receptor; Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Immunosuppressive Agents; Liver; Lymphoma, T-Cell, Peripheral; Lymphoproliferative Disorders; Male; Methylprednisolone; Pentostatin; Receptors, Antigen, T-Cell, gamma-delta; Remission Induction; Spleen; Transplantation, Homologous; Vidarabine | 2006 |
The pentostatin plus cyclophosphamide nonmyeloablative regimen induces durable host T cell functional deficits and prevents murine marrow allograft rejection.
Topics: Animals; Antineoplastic Agents; Bone Marrow Transplantation; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cyclophosphamide; Drug Synergism; Female; Graft Survival; Graft vs Host Disease; Immunosuppressive Agents; Interferon-gamma; Interleukin-2; Lymphocyte Depletion; Mice; Mice, Inbred BALB C; Pentostatin; Transplantation Chimera; Transplantation, Homologous; Vidarabine | 2011 |
An Unusual Protector-Protégé Strategy for the Biosynthesis of Purine Nucleoside Antibiotics.
Topics: Adenosine Deaminase; Anti-Bacterial Agents; Base Sequence; Cluster Analysis; Enzyme Inhibitors; Pentostatin; Sequence Analysis, DNA; Streptomyces antibioticus; Vidarabine | 2017 |
Beyond fludarabine: pentostatin plus cyclophosphamide are a well-tolerated alternative in reduced intensity conditioning.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Hematopoietic Stem Cell Transplantation; Humans; Pentostatin; Transplantation Conditioning; Vidarabine | 2022 |